| Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variant | |
| Song, Peng; Zhang, Jingcheng; Shang, Congcong; Zhang, Li | |
| 2018 | |
| 卷号 | 9期号:10页码:1327-1332 |
| 关键词 | Alectinib crizotinib EML4-ALK lung cancer |
| ISSN号 | 1759-7706 |
| DOI | 10.1111/1759-7714.12834 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6355609 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Song, Peng,Zhang, Jingcheng,Shang, Congcong,et al. Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variant[J],2018,9(10):1327-1332. |
| APA | Song, Peng,Zhang, Jingcheng,Shang, Congcong,&Zhang, Li.(2018).Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variant.,9(10),1327-1332. |
| MLA | Song, Peng,et al."Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variant".9.10(2018):1327-1332. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论